Description
Overview
Tesamorelin is a synthetic analog of the complete 44-amino-acid human growth hormone-releasing hormone. A trans-3-hexenoyl group attached to its N-terminus protects it from enzymatic breakdown while keeping the full native amino acid sequence. Tesamorelin is the active ingredient in an FDA-approved prescription medicine, and it is one of the most clinically characterized GHRH analogs, which makes it a common reference compound in growth hormone axis research.
Peptide Sciences Bio supplies Tesamorelin 2mg (10-vial kit) for in-vitro and preclinical laboratory investigation. Every batch is supported by independent analytical testing and a published Certificate of Analysis.
Product Specifications
| Product | Tesamorelin |
|---|---|
| Quantity | 2mg per vial; 10-vial kit (20mg total) |
| Class | Stabilized GHRH (1-44) analog |
| Length | 44 amino acids, N-terminal trans-3-hexenoyl group |
| Molecular formula | C221H366N72O67S |
| Molecular weight | 5135.9 g/mol |
| CAS number | 218949-48-5 |
| Form | Lyophilized powder |
| Purity | ≥99% (HPLC) |
| Documentation | Batch-specific Certificate of Analysis |
Structure & Background
Unlike GRF (1-29) analogs, tesamorelin keeps all 44 amino acids of native GHRH. Its only modification is the hexenoyl group on the N-terminal tyrosine, which blocks cleavage by DPP-4 at the start of the chain. This approach stabilizes the peptide without altering the receptor-binding sequence.
GHRH and GHRP Synergy
Growth hormone release is controlled by two main stimulatory signals. GHRH acts on the GHRH receptor and raises cAMP in pituitary somatotrophs. Ghrelin and the synthetic GHRPs act on a separate receptor, GHS-R1a, which works through calcium signaling and also counteracts somatostatin, the hormone that suppresses GH release. Because they use different pathways, research has consistently found that combining a GHRH analog with a GHRP produces a greater GH response than either compound alone, often more than the sum of the two. This synergy is the main reason these compounds are studied together.
Mechanisms Studied
Research on Tesamorelin has examined:
- GHRH receptor activation: stimulation of growth hormone synthesis and pulsatile release.
- IGF-1 axis: increased hepatic IGF-1 in pharmacology studies.
- Visceral adipose tissue: research on GH-mediated changes in abdominal fat depots.
- Hepatic lipid metabolism: studies of liver fat in clinical research populations.
Areas of Study
- Growth hormone axis pharmacology
- Visceral adiposity research
- Hepatic steatosis research
- Cognitive aging studies involving the GH axis
These findings come from laboratory, animal and clinical research on Tesamorelin as a pharmaceutical ingredient. They do not apply to this research-grade material, which is not an approved drug product and is not intended for human use.
Related Research Peptides
- Tesamorelin Peptide 5mg
- Tesamorelin + CJC-1295 (No DAC) + Ipamorelin 12mg (Blend)
- Tesamorelin, Ipamorelin 8mg (Blend)
- Ipamorelin Peptide 5mg
- CJC-1295 no DAC 2mg (Mod GRF 1-29)
- IGF-1 LR3 1mg
Quality & Testing
Every batch of Tesamorelin is independently tested for identity and purity before release. Testing includes high-performance liquid chromatography (HPLC) to confirm purity and mass spectrometry (MS) to confirm molecular identity. The batch-specific Certificate of Analysis is available on this page and in our COA library, so researchers can verify the exact material they receive.
Storage & Handling
- Store lyophilized Tesamorelin at −20°C, protected from light and moisture.
- Short-term storage at 2–8°C is acceptable for lyophilized material.
- Allow the vial to reach room temperature before opening to limit condensation.
- Handle using standard laboratory practices and appropriate protective equipment.
For laboratory solution preparation, see our Peptide Reconstitution Guide.
Frequently Asked Questions
What is Tesamorelin?
Tesamorelin is a stabilized analog of the full 44-amino-acid growth hormone-releasing hormone, studied in research on the growth hormone axis and visceral adipose tissue.
Is this the same as the prescription medicine?
No. Tesamorelin is the active ingredient in FDA-approved prescription medicines, but this product is not one of them. Peptide Sciences Bio’s Tesamorelin is a research-grade material that is not approved for human or veterinary use and is sold strictly for laboratory research.
How should Tesamorelin be stored?
Lyophilized Tesamorelin should be stored at −20°C, away from light and moisture. Short-term storage at 2–8°C is acceptable.
What does the Certificate of Analysis include?
Each COA reports the batch number, HPLC purity results and mass spectrometry confirmation of molecular identity for that specific batch.
Research Use Only
This product is intended solely for in-vitro research and laboratory experimentation by qualified professionals. It is not a drug, food, supplement or cosmetic, and it is not intended for human or veterinary use, or for the diagnosis, treatment or prevention of any condition. Purchase is restricted to buyers who agree to our Terms of Sale.
Additional information
| Product Form | Lyophilized Powder (Vial) |
|---|
Tesamorelin Peptide 2mg (10 Vial Kit)
$300.00 Original price was: $300.00.$250.00Current price is: $250.00.
Tesamorelin 2mg (10-vial kit) is a stabilized analog of full-length (1-44) GHRH with an N-terminal trans-3-hexenoyl group. It is studied in preclinical research on the growth hormone and growth factor axis. Supplied as a lyophilized powder at ≥99% purity (HPLC), with batch-specific COA available. For laboratory research use only.
Worldwide tracked delivery. Dispatched within 24 hours of order confirmation.
Not satisfied? Return any item within 10 days for a full refund, no questions asked.



